scispace - formally typeset
P

Pedro Sánchez-Godoy

Researcher at Rafael Advanced Defense Systems

Publications -  24
Citations -  558

Pedro Sánchez-Godoy is an academic researcher from Rafael Advanced Defense Systems. The author has contributed to research in topics: Follicular lymphoma & Fludarabine. The author has an hindex of 10, co-authored 22 publications receiving 431 citations.

Papers
More filters
Journal ArticleDOI

Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.

TL;DR: Mortality was associated with higher age, more comorbidities, type of hematological malignancy and type of antineoplastic therapy, and further studies and long-term follow-up are required to validate these criteria for risk stratification.
Journal ArticleDOI

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

TL;DR: FLT3-internal tandem duplication mutations are associated with several hematologic features in acute promyelocytic leukemia, in particular with high white blood cell counts, but it was unable to demonstrate an independent prognostic value in patients treated with all-trans retinoic acid and anthracycline-based regimens.